Decheng Capital LLC Legend Biotech Corp Transaction History
Decheng Capital LLC
- $746 Billion
- Q1 2024
A detailed history of Decheng Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Decheng Capital LLC holds 86,363 shares of LEGN stock, worth $4.09 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
86,363Holding current value
$4.09 Million% of portfolio
0.65%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$518 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$283 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$255 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$124 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$113 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.92B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...